首页> 美国卫生研究院文献>other >The trace amine associated receptor 1 agonist RO5263397 attenuates the induction of cocaine behavioral sensitization in rats
【2h】

The trace amine associated receptor 1 agonist RO5263397 attenuates the induction of cocaine behavioral sensitization in rats

机译:痕量胺相关受体1激动剂RO5263397减弱大鼠可卡因行为致敏的诱导

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The trace amine associated receptor (TAAR) 1 is a new G protein coupled receptor that critically modulates central dopaminergic system. Recently, several selective TAAR1 ligands have been described to possess antipsychotic and antidepressant-like activities. However, it is unknown of the role of these ligands in modulating psychostimulant-induced neurobehavioral plasticity. This study examined the effects of a selective TAAR1 agonist, RO5263397, on cocaine induced behavioral sensitization in rats, a rodent model of drug-induced behavioral plasticity. Daily treatment with 15 mg/kg cocaine (i.p., 7 days) induced robust locomotor sensitization in rats. RO5263397 (1–10 mg/kg, i.p.) alone did not significantly alter the locomotor activity. Acute treatment with RO5263397 (3.2 and 10 mg/kg) did not significantly modify cocaine-induced hyperactivity; however, the induction of locomotor sensitization was significantly blocked after 7 days of daily RO5263397 treatment. More importantly, the expression of locomotor sensitization remained significantly attenuated when rats were re-tested 7 days after the last drug treatment. The marked attenuation of cocaine sensitization was also evidenced by the suppression of the dose-effect function (3.2 – 32 mg/kg) of cocaine sensitization. Together, these data represent the first to report a critical modulatory role of TAAR 1 agonists in cocaine-induced behavioral plasticity, which may be indicative of its potential role for altering other long-lasting behavioral maladaptations of cocaine including drug addiction.
机译:痕量胺相关受体(TAAR)1是一种新的G蛋白偶联受体,主要调节中央多巴胺能系统。近来,已经描述了几种选择性TAAR1配体具有抗精神病药和抗抑郁药样的活性。然而,尚不清楚这些配体在调节精神刺激剂诱导的神经行为可塑性中的作用。这项研究检查了选择性TAAR1激动剂RO5263397对可卡因诱导的大鼠行为敏化的影响,大鼠是药物诱发的行为可塑性的啮齿动物模型。每天用15 mg / kg可卡因治疗(即7天)可在大鼠中引起强烈的运动敏化。单独使用RO5263397(1-10 mg / kg,腹腔注射)不会显着改变运动能力。用RO5263397(3.2和10 mg / kg)进行的急性治疗并未显着改变可卡因诱导的机能亢进。然而,每天进行RO5263397治疗7天后,运动敏化的诱导被显着阻断。更重要的是,在最后一次药物治疗后7天重新测试大鼠时,运动敏化的表达仍显着减弱。可卡因致敏作用的明显减弱还通过抑制可卡因致敏的剂量效应功能(3.2 – 32 mg / kg)来证明。总之,这些数据首次报道了TAAR1激动剂在可卡因诱导的行为可塑性中的关键调节作用,这可能表明其可能改变可卡因的其他长期行为不适应症,包括药物成瘾。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号